Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The Cdc25A protein phosphatase drives cell-cycle transitions by activating cyclin-dependent protein kinases. Failure to regulate Cdc25A leads to deregulated cell-cycle progression, bypass of cell-cycle checkpoints and genome instability. Ubiquitin-mediated proteolysis has an important role in balancing Cdc25A levels. Cdc25A contains a DS82G motif whose phosphorylation is targeted by β-TrCP E3 ligase during interphase. Targeting β-TrCP to Cdc25A requires phosphorylation of serines 79 (S79) and 82 (S82). Here, we report that casein kinase 1 α (CK1α) phosphorylates Cdc25A on both S79 and S82 in a hierarchical manner requiring prior phosphorylation of S76 by Chk1 or GSK-3β. This facilitates β-TrCP binding and ubiquitin-mediated proteolysis of Cdc25A throughout interphase and after exposure to genotoxic stress. The priming of Cdc25A by at least three kinases (Chk1, GSK-3β, CK1α), some of which also require priming, ensures diverse extra- and intracellular signals interface with Cdc25A to precisely control cell division.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084 · cited 1×
“Inactivation of GSK-3β in various cancer cells through constitutive activation of the PI3K- or MAPK-pathways accounts for Cdc25A overproduction in a subset of tumors (Cohen and Frame, 2001; Doble and Woodgett, 2003; Zhou et al., 2004; Kang et al., 2008).”
BackgroundZhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581 · cited 3×
“Inactivation of GSK-3β in various cancer cells through constitutive activation of the PI3K- or MAPK-pathways accounts for Cdc25A overproduction in a subset of tumors (Cohen and Frame, 2001; Doble and Woodgett, 2003; Zhou et al., 2004; Kang et al., 2008).”
BackgroundMethodThe ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085 · cited 5×
“Cdc25A is also rapidly targeted for ubiquitin-mediated proteolysis when cells experience genotoxic or replication stress and failure to degrade Cdc25A during a checkpoint response leads to bypass of the S- and G2-checkpoints (Mailand et al., 2000; Molinari et al., 2000; Falck et al., 2001; Zhao et al., 2002; Hassepass…”
BackgroundInfluentialRapid Destruction of Human Cdc25A in Response to DNA Damage
Mailand, N., Falck, J., Lukas, C., Syljuåsen, R. G., Welcker, M., Bartek, J., & Lukas, J. (2000) · Science · doi:10.1126/science.288.5470.1425 · Cited by 787
The casein kinase 1 family: participation in multiple cellular processes in eukaryotes
Knippschild, U., Gocht, A., Wolff, S., Huber, N., Löhler, J., & Stöter, M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.12.011 · Cited by 601
Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
Busino, L., Donzelli, M., Chiesa, M., Guardavaccaro, D., Ganoth, D., Valerio Dorrello, N., Hershko, A., Pagano, M., & Draetta, G. F. (2003) · Nature · doi:10.1038/nature02082 · Cited by 447 · cited 10×
“3A) (Busino et al., 2003; Jin et al., 2003).”
BackgroundInfluentialSCFβ-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase
Jin, J., Shirogane, T., Xu, L., Nalepa, G., Qin, J., Elledge, S. J., & Harper, J. W. (2003) · Genes & Development · doi:10.1101/gad.1157503 · Cited by 340
Kanemori, Y., Uto, K., & Sagata, N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501873102 · Cited by 128 · cited 2×
“These motifs are conserved in several higher eukaryotes (Supplementary Figure S5), with the notable exception of Xenopus Cdc25A, which exclusively uses the DDGFXD motif (Kanemori et al., 2005).”
BackgroundRegulation of p53-MDMX interaction by casein kinase 1 alpha
Chen, L., Li, C., Pan, Y., & Chen, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6509-6520.2005 · Cited by 88 · cited 3×
“Plasmids encoding CK1α and Myc-β-TrCP1 were provided by Dr. Jiandong Chen (Chen et al., 2005) and Dr. Binhua P. Zhou (Zhou et al, 2004), respectively.”
Method
Cited by
The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis
Knippschild, U., Krüger, M., Richter, J., Xu, P., GarcÃa-Reyes, B., Peifer, C., Halekotte, J., Bakulev, V., & Bischof, J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00096 · Cited by 272
14-3-3 proteins as signaling integration points for cell cycle control and apoptosis
Gardino, A. K., & Yaffe, M. B. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2011.09.008 · Cited by 263
Ubiquitin Ligases and Cell Cycle Control
Teixeira, L. K., & Reed, S. I. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060410-105307 · Cited by 252
Casein kinase 1α: biological mechanisms and theranostic potential
Jiang, S., Zhang, M., Sun, J., & Yang, X. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0236-z · Cited by 130
CK1α overexpression correlates with poor survival in colorectal cancer
Richter, J., Kretz, A.-L., Lemke, J., Fauler, M., Werner, J.-U., Paschke, S., Leithäuser, F., Henne-Bruns, D., Hillenbrand, A., & Knippschild, U. (2018) · BMC Cancer · doi:10.1186/s12885-018-4019-0 · Cited by 28
Liu, O.-G., Xiong, X.-Y., Li, C.-M., Zhou, X.-S., & Li, S.-S. (2018) · Medical Science Monitor · doi:10.12659/msm.905319 · Cited by 4
Metadata
- Authors
- Honaker, Y., & Piwnica-Worms, H.
- Venue
- Oncogene
- Published
- 2010-03-29
- Volume
- 29
- Issue
- 23
- Pages
- 3324-3334
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2059277316
- Cited by
- 75
- References
- 9
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.